Combination therapy of her expressing tumors
US8163287B2 · kind B2 · utility
32Cited by
48References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2006 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | Dec 7, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to tumors expressing HER2 and EGFR, using HER2-dimerization inhibitors (HDIs) and EGFR inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.